The increase of hepatic apoB-containing lipoprotein production is considered as the principal defect in subjects with familial combined hyperlipidemia [38], [39], and is also considered as an important component of the dyslipidemia of diabetes and obesity [40], [41]. The gene discussed is APOB; the disease is metabolic syndrome.